China Medical System eyes secondary listing on SGX in July

It aims to expand its Southeast Asia presence and reach Singapore investors.

China Medical System Holdings Limited (CMS), a pharmaceutical company headquartered in Hong Kong, plans to pursue a secondary listing on the Mainboard of the Singapore Exchange (SGX) in July 2025.

Already listed on the Hong Kong Stock Exchange since 2010, CMS has been part of the Hang Seng Large-Mid Cap (Investable) Index and the Hang Seng Innovative Drug Index since 2020 and 2023, respectively.

The secondary listing on SGX aims to deepen CMS’s presence in Southeast Asia and tap into a new investor base in Singapore.

Building on its proven track record attained in China’s pharmaceutical industry, CMS is looking to replicate its success in Southeast Asia.

The group has established Rxilient Health in Singapore as its regional hub, supported by subsidiaries or offices in Malaysia, Vietnam, the Philippines, Indonesia, and Thailand.

To deepen its roots in Southeast Asia, CMS has also acquired a Contract Development and Manufacturing Organisation in Singapore through its associated company, PharmaGend Global.

The 60,290 sqm manufacturing site in Singapore has an annual production capacity of 1 billion oral solid dosage tablets and capsules and started commercial supply production at the end of 2024.

Follow the link for more news on

SGX

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia